Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uta Schönfelder

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Mycoses|December 14, 2011
A real-time PCR for the detection and characterisation of Aspergillus speciesStephan Fricke, Christian Fricke, Christopher Oelkrug, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2010
Characterization of murine non-adherent bone marrow cells leading to recovery of endogenous hematopoiesisStephan Fricke, Christian Fricke, Christopher Oelkrug, et al.
International Journal of Radiation Biology|March 11, 2014
Modelling hematological parameters after total body irradiationChristopher Oelkrug, Nadja Hilger, Uta Schönfelder, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 24, 2012
Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failureStephan Fricke, Katherina Rothe, Nadja Hilger, et al.
Cellular and Molecular Life Sciences : CMLS|September 27, 2013
Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4(+) T-cellsStephan Fricke, Nadja Hilger, Christian Fricke, et al.
Journal of Cancer Research and Clinical Oncology|November 28, 2012
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myelomaWolfram Pönisch, Malvina Bourgeois, Barbara Moll, et al.
Journal of Cancer Research and Clinical Oncology|January 12, 2021
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)Tanja Holzhey, Wolfram Pönisch, Song-Yau Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Mycoses|December 14, 2011
A real-time PCR for the detection and characterisation of Aspergillus speciesStephan Fricke, Christian Fricke, Christopher Oelkrug, et al.
Cellular and Molecular Life Sciences : CMLS|June 18, 2010
Characterization of murine non-adherent bone marrow cells leading to recovery of endogenous hematopoiesisStephan Fricke, Christian Fricke, Christopher Oelkrug, et al.
International Journal of Radiation Biology|March 11, 2014
Modelling hematological parameters after total body irradiationChristopher Oelkrug, Nadja Hilger, Uta Schönfelder, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 24, 2012
Allogeneic bone marrow grafts with high levels of CD4(+) CD25(+) FoxP3(+) T cells can lead to engraftment failureStephan Fricke, Katherina Rothe, Nadja Hilger, et al.
Cellular and Molecular Life Sciences : CMLS|September 27, 2013
Prevention of graft-versus-host-disease with preserved graft-versus-leukemia-effect by ex vivo and in vivo modulation of CD4(+) T-cellsStephan Fricke, Nadja Hilger, Christian Fricke, et al.
Journal of Cancer Research and Clinical Oncology|November 28, 2012
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myelomaWolfram Pönisch, Malvina Bourgeois, Barbara Moll, et al.
Journal of Cancer Research and Clinical Oncology|January 12, 2021
Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV)Tanja Holzhey, Wolfram Pönisch, Song-Yau Wang, et al.
Pageof 1